Inscription Capital’s Columbia Research Enhanced Core ETF RECS Stock Holding History
Bought
Maintained
Sold
Other funds holding RECS
GI
BWL
Inscription Capital's RECS Position: Q2 2026 in Review
Inscription Capital reduced its Columbia Research Enhanced Core ETF (RECS) stake by 38% in Q2 2026, selling an estimated $746K and leaving 28,974 shares worth $1.25M. The position accounts for 0.11% of the portfolio, ranked #172.
Inscription Capital first reported a position in RECS in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.05M in Q4 2025. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.
- Inscription Capital held 28,974 shares of Columbia Research Enhanced Core ETF worth $1.25M as of Q2 2026.
- Inscription Capital sold 17,605 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $746K.
- Columbia Research Enhanced Core ETF made up 0.11% of Inscription Capital's portfolio in Q2 2026, its #172 holding.
- Inscription Capital first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 5 quarters since.
- Inscription Capital's Columbia Research Enhanced Core ETF position peaked at $2.05M in Q4 2025.
- 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.